A novel compound against breast cancer improves the efficacy of standard cancer treatment and shows superior tolerabilit...
Most contaminants are invisible to the naked eye. Micro-organisms are fairly small, they pose a severe threat to the saf...
Berkeley Lights, Inc. and Novo Nordisk have announced that Novo Nordisk has purchased the Beacon Optofluidic platform to...
The Menarini Group has recently reached an agreement with Melinta Therapeutics to commercialize meropenem/vaborbactam in...
Batavia Biosciences has announced that the International AIDS Vaccine Initiative (IAVI) and Batavia Bioscience...
Tissue Genesis LLC announced today the release of the Icellator® X, the newest and most advanced system for isolatin...
Roche has announced that it entered into a collaboration with Merck (known as MSD outside the United States and Canada) ...
Roche has announced that Daniel O'Day, CEO Roche Pharmaceuticals and member of the Corporate Executive Committee, will b...
US based company GenEdit has announced the completion of a $8.5 million Series Seed financing round led by new...
Gilead Sciences Inc. a research-based biopharmaceutical company that discovers, develops and commercializes innovative m...
Trianni, Inc. and MacroGenics, Inc. has announced that they have entered into a license agreement for The Trianni Mouse,...
Merck, a leading science and technology company has entered into a licensing agreement with Cyclica Inc. for the use of ...
Seattle-based biotechnology company, Impel NeuroPharma has announced that it has completed a Series D financing totaling...
Diamyd Medical is dedicated to finding a cure for diabetes and other serious inflammatory diseases through pharmaceutica...
Based on its recent analysis of the North American medication adherence market, Frost & Sullivan recognizes Phi...
Vienna-based Biotech Company PhagoMed Biopharma GmbH was yesterday awarded the Austrian Entrepreneurship Award Phön...
Medical Devices company, ResMed has announced that it has entered a definitive agreement to acquire Propeller Health, a ...
Pharma company, Domain Therapeutics has announced a multi-targetdrug discovery collaboration and licensing agreement wit...
